Paul Zorsky
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation 4
- Multiple Myeloma Research and Treatments 2
-
- Cancer Treatment and Pharmacology 3
- Bone health and treatments 2
- Neutropenia and Cancer Infections 2
- Orthopedics and Sports Medicine top 10%
-
- Neuroendocrine Tumor Research Advances 5
-
- Immune Cell Function and Interaction 2
- Immunotherapy and Immune Responses 2
- Co-authors
- Gerald J. ElfenbeinKaren K. FieldsJ. HiemenzWilliam E. JanssenOscar BallesterJanelle PerkinsWendy YingRajul K. Jain
- Journals
- Journal of Clinical Oncology (3 papers)Immunological Investigations (2 papers)The American Journal of the Medical Sciences (2 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Paul Zorsky
16 papers receiving 385 citations
Peers
Comparison fields: 5 of 66
- Hematology 127
- Oncology 208
- Orthopedics and Sports Medicine 57
- Nephrology 21
- Transplantation 7
Countries citing papers authored by Paul Zorsky
This map shows the geographic impact of Paul Zorsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Zorsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Zorsky more than expected).
Fields of papers citing papers by Paul Zorsky
This network shows the impact of papers produced by Paul Zorsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Zorsky. The network helps show where Paul Zorsky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Zorsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 106 | |
| 2 | 2013 | 1 | |
| 3 | 2010 | 2 | |
| 4 | 2009 | 14 | |
| 5 | 2002 | 13 | |
| 6 | 1997 | 58 | |
| 7 | 1997 | 1 | |
| 8 | 1997 | 10 | |
| 9 | 1997 | 6 | |
| 10 | 1995 | 59 | |
| 11 | 1994 | 45 | |
| 12 | 1993 | 11 | |
| 13 | Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities. | 1993 | 30 |
| 14 | The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding. | 1993 | 28 |
| 15 | 1992 | 7 | |
| 16 | 1973 | 8 |
About Paul Zorsky
Paul Zorsky is a scholar working on Hematology, Pharmacy and Oncology, having authored 16 papers that have together received 399 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Cancer Treatment and Pharmacology (3 papers), Bone health and treatments (2 papers), Multiple Myeloma Research and Treatments (2 papers), Immune Cell Function and Interaction (2 papers), Neutropenia and Cancer Infections (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Hematology (127 citations), Oncology (208 citations) and Orthopedics and Sports Medicine (57 citations). Paul Zorsky has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Gerald J. Elfenbein, Karen K. Fields, J. Hiemenz, William E. Janssen, Oscar Ballester, Janelle Perkins, Wendy Ying, Rajul K. Jain, Sophie Leboulleux and Waldemar Misiorowski. Their work appears in journals such as Journal of Clinical Oncology, Immunological Investigations, The American Journal of the Medical Sciences, British Journal of Haematology and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.